Loading clinical trials...
Loading clinical trials...
Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After Vaccination With the Gardasil-9 HPV Vaccine - a Non-randomized Open-label Study.
Conditions
Interventions
Gardasil 9 (2 dose regimen)
Locations
3
Belgium
Antwerp University Hospital
Antwerp, Wilrijk, Belgium
University Hospital Ghent
Ghent, Belgium
University Hospital Leuven
Leuven, Belgium
Start Date
March 25, 2026
Primary Completion Date
January 1, 2029
Completion Date
January 1, 2029
Last Updated
March 27, 2026
NCT02733068
NCT02546752
Lead Sponsor
Universiteit Antwerpen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions